<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01042613</url>
  </required_header>
  <id_info>
    <org_study_id>ACVEIN</org_study_id>
    <nct_id>NCT01042613</nct_id>
  </id_info>
  <brief_title>A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique</brief_title>
  <official_title>A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Children's Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Children's Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. This study will compare the first attempt success rate of cannulation in research
           participants randomized to using a new FDA approved AccuVein AV300 device for
           intravenous access with research participants randomized to standard cannulation
           methods.

        2. This study will assess if insertion of intravenous cannula is faster when intravenous
           access is assisted by the AccuVein AV300 device as compared to the standard technique.

        3. This study will assess if the number of skin punctures is fewer when intravenous access
           is assisted by the AccuVein AV300 device as compared to the standard technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients agreeing to participate in this study will be randomized to one of two groups for
      intravenous access. One group will use the standard cannulation method and the other group
      will use the new FDA approved AccuVein AV300 device for cannulation.

      After pre-anesthetic evaluation, the research participant will be brought to the operating
      room or magnetic resonance imaging (MRI) Suite and standard monitoring will be applied (EKG,
      SpO2, BP) if tolerated. Anesthesia will be induced via a face mask with sevoflurane in 100%
      O2. When the supervising anesthesiologist deems it appropriate, attempt at cannulation will
      begin.

      A tourniquet will be applied. A 22-gauge cannula will be used. Randomization will take place
      before the patient is taken back to the Operating Room or MRI Suite. If the research
      participant has been randomized to the standard treatment group then cannulation will be
      attempted in the standard manner. If the research participant has been randomized to the
      AV300 device group then intravenous cannulation will be attempted using the AV300 device
      following the manufacturer's instructions.

      A research team member will time cannulation access for all participants. Participation ends
      once successful cannulation is achieved or when a maximum of 4 skin punctures have been made.

      Only the study coordinator will know which randomization group the patient has been assigned.
      Once the anesthesiologist has determined a potential IV access site, s/he will be informed to
      which group the patient was assigned. If the parent/guardian requests, s/he will be told
      after the procedure to which group the child was randomized.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Attempt Success Rate of Cannulation</measure>
    <time_frame>At cannulation</time_frame>
    <description>This study will compare the first attempt success rate of cannulation in research participants randomized to using a new FDA approved AccuVein AV300 device for intravenous access with research participants randomized to standard cannulation methods. There is one timepoint for outcome data collection and it is prior to cannulation. Success (yes) is defined as needle insertion into target vein.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time Between Tourniquet Application and Successful Cannulation is Achieved or 4 Attempts Have Been Made (in Minutes).</measure>
    <time_frame>At cannulation</time_frame>
    <description>To assess if insertion of intravenous cannula is faster when intravenous access is assisted by the AccuVein AV 300 device as compared to the standard technique</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Skin Punctures</measure>
    <time_frame>At cannulation</time_frame>
    <description>To assess if the number of skin punctures is fewer when intravenous access is assisted by the AccuVein AV300 device as compared to the standard technique</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Cannulation</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>(standard technique of insertion of the intravenous cannula)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cannulation using Accuvein device</intervention_name>
    <description>If the research participant has been randomized to the AV300 device group A, then intravenous cannulation will be attempted using the AV300 device following manufacturer's instructions by four anesthesiologists.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Cannulation method</intervention_name>
    <description>If the research participant has been randomized to the standard treatment group B then cannulation will be attempted in the standard manner. A research team member will time cannulation access for all participants. Participation ends once successful cannulation is achieved or when a maximum of 4 skin punctures have been made.</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Infants and children under 18 years of age.

          2. American Society of Anesthesiologist (ASA) Physical Status I, II or III.

          3. Patients undergoing elective surgery,examination under anesthesia,or MRI who do not
             have existing intravenous access.

          4. Able to understand English.

          5. Parent/guardian willing to sign consent.

        Exclusion Criteria:

          1. Existing intravenous access.

          2. Malformations or infections at the potential site of insertion.

          3. Inability or unwillingness of research participant or legal guardian/representative to
             give written informed consent.

          4. Need for emergency surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Trujillo Huaccho, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Jude Children's Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St . Jude Children's Research Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.stjude.org</url>
    <description>St. Jude Children's Research Hospital</description>
  </link>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2010</study_first_submitted>
  <study_first_submitted_qc>January 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2010</study_first_posted>
  <results_first_submitted>September 9, 2011</results_first_submitted>
  <results_first_submitted_qc>November 2, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 7, 2011</results_first_posted>
  <last_update_submitted>November 2, 2011</last_update_submitted>
  <last_update_submitted_qc>November 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AccuVein AV300 device;</keyword>
  <keyword>Intravenous cannulation</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>148 total patients were recruited at single institution (SJCRH) study between Jan 13, 2010, and March 03, 2011.</recruitment_details>
      <pre_assignment_details>148 total patients were enrolled on the study. The report is based on results for 146 patients. Two patients were excluded from this study. One patient was excluded due to MDâ€™s decision and the other patient was deemed to be inevaluable after study enrollment (cannula gauge other than 22 were used).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ACVein</title>
          <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
        </group>
        <group group_id="P2">
          <title>Standard</title>
          <description>(standard technique of insertion of the intravenous cannula)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="72"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="72"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ACVein</title>
          <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
        </group>
        <group group_id="B2">
          <title>Standard</title>
          <description>(standard technique of insertion of the intravenous cannula)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="72"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="146"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.72" spread="3.72"/>
                    <measurement group_id="B2" value="5.37" spread="3.88"/>
                    <measurement group_id="B3" value="5.54" spread="3.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Attempt Success Rate of Cannulation</title>
        <description>This study will compare the first attempt success rate of cannulation in research participants randomized to using a new FDA approved AccuVein AV300 device for intravenous access with research participants randomized to standard cannulation methods. There is one timepoint for outcome data collection and it is prior to cannulation. Success (yes) is defined as needle insertion into target vein.</description>
        <time_frame>At cannulation</time_frame>
        <population>Patients (age 17 years or less) undergoing elective surgery or examination under anesthesia who do not have existing intravenous access.</population>
        <group_list>
          <group group_id="O1">
            <title>ACVein</title>
            <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
          </group>
          <group group_id="O2">
            <title>Standard</title>
            <description>(standard technique of insertion of the intravenous cannula)</description>
          </group>
        </group_list>
        <measure>
          <title>First Attempt Success Rate of Cannulation</title>
          <description>This study will compare the first attempt success rate of cannulation in research participants randomized to using a new FDA approved AccuVein AV300 device for intravenous access with research participants randomized to standard cannulation methods. There is one timepoint for outcome data collection and it is prior to cannulation. Success (yes) is defined as needle insertion into target vein.</description>
          <population>Patients (age 17 years or less) undergoing elective surgery or examination under anesthesia who do not have existing intravenous access.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Successful first attempt</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsuccessful first attempt</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.851</p_value>
            <method>Fisher Exact</method>
            <param_type>Difference of the Binomial Proportions</param_type>
            <param_value>.02</param_value>
            <ci_percent>95</ci_percent>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Between Tourniquet Application and Successful Cannulation is Achieved or 4 Attempts Have Been Made (in Minutes).</title>
        <description>To assess if insertion of intravenous cannula is faster when intravenous access is assisted by the AccuVein AV 300 device as compared to the standard technique</description>
        <time_frame>At cannulation</time_frame>
        <population>Of the 146 patients, two patients were excluded due to missing time records.</population>
        <group_list>
          <group group_id="O1">
            <title>ACVein</title>
            <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
          </group>
          <group group_id="O2">
            <title>Standard</title>
            <description>(standard technique of insertion of the intravenous cannula)</description>
          </group>
        </group_list>
        <measure>
          <title>Time Between Tourniquet Application and Successful Cannulation is Achieved or 4 Attempts Have Been Made (in Minutes).</title>
          <description>To assess if insertion of intravenous cannula is faster when intravenous access is assisted by the AccuVein AV 300 device as compared to the standard technique</description>
          <population>Of the 146 patients, two patients were excluded due to missing time records.</population>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
                <count group_id="O2" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.48" spread=".97"/>
                    <measurement group_id="O2" value="1.26" spread=".84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.105</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>.22</param_value>
            <ci_percent>95</ci_percent>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Skin Punctures</title>
        <description>To assess if the number of skin punctures is fewer when intravenous access is assisted by the AccuVein AV300 device as compared to the standard technique</description>
        <time_frame>At cannulation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACVein</title>
            <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
          </group>
          <group group_id="O2">
            <title>Standard</title>
            <description>(standard technique of insertion of the intravenous cannula)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Skin Punctures</title>
          <description>To assess if the number of skin punctures is fewer when intravenous access is assisted by the AccuVein AV300 device as compared to the standard technique</description>
          <units>Skin punctures</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.33" spread=".75"/>
                    <measurement group_id="O2" value="1.26" spread=".62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.8</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>.07</param_value>
            <ci_percent>95</ci_percent>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 minutes per patient</time_frame>
      <desc>Enrollment was from January, 2010 through March, 2011. Patients were off study at completion of cannulation.</desc>
      <group_list>
        <group group_id="E1">
          <title>ACVein</title>
          <description>Research participants are randomly assigned into group A (Accuvein AV300 assisted intravenous catheter insertion)</description>
        </group>
        <group group_id="E2">
          <title>Standard</title>
          <description>(standard technique of insertion of the intravenous cannula)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Luis Trujillo Huaccho, MD</name_or_title>
      <organization>St. Jude Children's Research Hospital</organization>
      <phone>1-866-278-5833</phone>
      <email>info@stjude.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

